Clinical trial
The Effect of Celecoxib on Neuroinflammation in MDD
NCT04814355
Study timeline
Study start (actual)2018-08-01Date precision: day
Registry last updated2026-04-24
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Major Depressive Disorderunresolved
Neuroinflammationunresolved
Interventions
Celecoxib 400 mgDRUG · verified · RxNorm: celecoxib 400 MG
Sponsors & collaborators
Stony Brook Universitylead sponsor
Brain & Behavior Research Foundationcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04814355 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.